About this trial
This is a longitudinal, multi-center, registry study, collecting data via a web-based portal in patients with GIST (Gastrointestinal Stromal Tumor) from hospitals in Taiwan.
Eligibility criteria
Qualifiers
Patients diagnosed with Gastrointestinal Stromal Tumor
≥20 years old
Histology-confirmed GIST between 01 January 2010 and 31 December 2020.
Patient with prospective data collection: Willing to provide singed inform-consent as per local regulatory requirements.
Disqualifiers
Inability and unwillingness to give informed consent if required by site ethic committee.
Patient that is unlikely candidate to obtain long-term follow-up information for reasons of unavailability or with severe concomitant illnesses per investigator judgement
Trial design
Treatments tested in this trial
- Observation
Treatment groups
Sponsors and collaborators
National Health Research Institutes, Taiwan
Lead sponsor
Taipei Veterans General Hospital, Taiwan
Collaborator
National Taiwan University Hospital
Collaborator
China Medical University Hospital
Collaborator
Changhua Christian Hospital
Collaborator
Chang Gung Memorial Hospital
Collaborator
National Cheng-Kung University Hospital
Collaborator
Kaohsiung Medical University
Collaborator
Taichung Veterans General Hospital
Collaborator